VKTX: the balance sheet

MyFinsight

For the year ending 2025-12-31, VKTX has $715,729K in assets. $76,667K in debts. $165,810K in cash and cash equivalents.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Balance Sheets	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Cash and cash equivalents	165,810	26,676	55,516	36,632
Short-term investments available for sale	539,929	875,936	306,563	118,853
Prepaid clinical trial and preclinical study costs	8,053	3,476	2,624	8,144
Prepaid expenses and other current assets	1,806	1,128	2,522	3,411
Total current assets	715,598	907,216	367,225	167,040
Right-of-use assets	85	1,003	1,126	1,418
Deferred financing costs	0	56	106	38
Deposits	46	46	33	33
Total assets	715,729	908,321	368,490	168,529

Accounts payable	53,251	9,813	7,512	8,529
Other accrued liabilities	23,279	17,111	11,299	13,114
Lease liability, current	137	489	324	304
Total current liabilities	76,667	27,413	19,135	21,947
Lease liability, net of current portion	0	630	936	1,260
Total long-term liabilities	0	630	936	1,260
Total liabilities	76,667	28,043	20,071	23,207
Common stock, 0.00001 par value 300,000,000 shares authorized at december 31, 2025 and december 31, 2024 114,793,067 shares issued and outstanding at december 31, 2025 and 111,573,519 shares issued and outstanding at december 31, 2024	1	1	1	1
Treasury stock at cost, no shares at december 31, 2025 and december 31, 2024	0	0	6,795	6,795
Additional paid-in capital	1,486,229	1,368,972	733,546	445,267
Accumulated deficit	-847,546	-487,907	-377,944	-292,049
Accumulated other comprehensive loss	378	-788	-389	-1,102
Total stockholders equity	639,062	880,278	348,419	145,322
Total liabilities and stockholders equity	715,729	908,321	368,490	168,529

Unit: Thousand (K) dollars